Share This

Related Topics News -

     
 Title only   |   Print    Next page > 
     
三生製藥簽訂司美格魯肽注射液合作協議

2024-05-29T  
三生製藥特比澳新適應症申請獲批

2024-04-14T  
《大行報告》大摩降三生製藥目標價至7.5元 評級「與大市同步」

2024-04-08T  
《大行報告》中銀國際降三生製藥目標價至6.2元 去年下半年純利低於預期

2024-03-25T  
《大行報告》里昂升三生製藥目標價至6.2元 評級「跑贏大市」

2024-03-22T  
三生製藥建議回購股份

2024-03-21T  
《公司業績》三生製藥全年純利15.49億人民幣跌19% 末期息派25港仙

2024-03-21T  
內地擬成立生物醫藥產業工作組 推進生物醫藥產業數字化轉型

2024-03-12T  
《全日總結》恆指升132點 美團及招行漲逾5% 小鵬揚近8%

2024-02-14T  
《半日總結》恆指倒升23點 濠賭股造好 小鵬彈逾5%

2024-02-14T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.